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Abstract
We present a new method for testing association when data from both case-parents trios and
unrelated controls are available. Our method combines test statistics for case-parents trio and
unrelated case-control studies by adjusting for the correlation that arises when the same set of
cases is used for both tests. We further consider several analytical approaches for two-stage
studies on a large number of markers, including methods based on the joint analysis. The
performance of the proposed approaches is examined by analyzing the simulated data provided by
the Genetic Analysis Workshop 15.
Background
Genetic association studies are a popular method to detect
genetic markers associated with a complex human dis-
ease. Two common designs in genetic association studies
are family-based designs using case-parents trios and pop-
ulation-based designs using unrelated cases and controls.
The transmission disequilibrium test (TDT) is frequently
used to analyze the case-parents trio data [1]. The TDT
tests for both linkage and association and is not sensitive
to population admixture and stratification. Using a likeli-
hood approach, Schaid and Sommer [2] proposed TDT-
type statistics that are more powerful than the TDT for a
specific genetic model (see also [3]). For the unrelated
case-control design, a linear trend test [4], which is often
more powerful than the TDT based on case-parents trios,
can be considered specifically when obtaining a sufficient
number of trios is difficult.
Data that contain both case-parents trios and unrelated
cases and controls on the same set of markers are increas-
ingly available. Nagelkerke et al. [5] provided a few situa-
tions where such a mixture of case-parents trios and
unrelated cases and controls can occur: 1) a case-parents
trio design was originally considered and then unrelated
controls were added, 2) a case-control design was origi-
nally considered and then the parents of the cases were
added to confirm the findings. Such designs are typically
analyzed in two stages, and strategies for analyzing this
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type of data while fully utilizing the given information are
important.
In this paper, we study several approaches for testing
genome-wide association in such situations. Based on the
design, either a TDT-type statistic or a linear trend test will
be used in the first stage to select a proportion of markers
that will be tested in the second stage. The other test will
then be applied in the second stage while controlling the
genome-wide false positive rates by adjusting for the cor-
relation with the first stage. Following a recently proposed
method by Skol et al. [6], we also study a joint analysis for
the second stage.
Methods
Consider a marker with two alleles, M and N, where M
itself is a risk allele or is in linkage disequilibrium with a
risk allele with frequency p, and N is a normal allele with
frequency q = 1 - p. Penetrances are defined as the proba-
bilities of disease conditional on the genotypes, that is, f0
= Pr(disease|NN), f1 = Pr(disease|NM), and f2 = Pr(dis-
ease|MM). No association implies f0 = f1 = f2, whereas f0 ≤
f1 ≤ f2 with at least one strict inequality implies there is an
association between the marker and a disease. Using f0 as
a baseline penetrance, the genotype relative risks are
defined as ψi = fi/f0 for i = 1, 2. A genetic model is recessive,
additive, or dominant when f0 = f1 (or ψ1 = 1, ψ2 = ψ), f1 =
(f0 + f2)/2 (or ψ1 = ψ, ψ2 = 2ψ-1), or f1 = f2 (or ψ1 = ψ2 = ψ).
Case-parents trio design
In the case-parents trio design, cases and their parents are
selected from the population and their genotypes are
obtained. There are six possible parental mating types for
a marker with two alleles M and N: 1) MM × MM, 2) MM
× NM, 3) MM × NN, 4) NM × NM, 5) NM × NN, and 6)
NN × NN. These six mating types are given in the first col-
umn of Table 1. The second column provides case geno-
types for each mating type, and the third column is the
sample size of trios under each mating type. The probabil-
ities of parental mating types can be calculated by assum-
ing Hardy-Weinberg equilibrium (HWE), and the
probability of each nij can then be obtained and is pre-
sented in the fourth column. The last column contains the
probabilities of a case genotype given parental mating
type (Schaid and Sommer [2]).
Schaid and Sommer [2] suggested an analysis conditional
on parental mating types that provides unbiased estimates
of genotype relative risks. Denote the likelihood function
for a given model as L(ψ), then the score test for H0: ψ = 1
can be obtained by ∂logL(ψ)/∂ψ/{-∂2logL(ψ)/∂ψ2}1/2|ψ =
1.
Unrelated case-control design
For the unrelated case-control design, denote the geno-
type counts of three genotypes NN, MN and MM as (r0, r1,
r2) in cases and (s0, s1, s2) in controls that follow multino-
mial distributions mul(R: p0, p1, p2) and mul(S: q0, q1, q2).
Then the null hypothesis of no association implies pi = qi
for each i.
Sasieni [4] proposed a method that uses the marker geno-
type as a covariate in the logistic regression model where
the genotype is coded by increasing scores, that is, 0, x,
and 1 for NN, NM, and MM, where 0 ≤ x ≤ 1. The optimal
scores for recessive, additive and dominant models are x =
0, 1/2, and 1 [4,7] and the trend test [7] is given by
, where Z
Ux
Var U x
CC =
()
(() )
Table 1: Conditional probabilities of genotype given parental mating types and offspring disease status
Parental mating type Case genotype Count Probability of trio Conditional probability
1) MM × MM MM n12 p4ψ2/T 1
2) MM × NM MM n22 2p3q(ψ1 + ψ2)/T ψ2/(ψ1 + ψ2)
NM n21 ψ1/(ψ1 + ψ2)
3) MM × NN NM n31 2p2q2ψ1/T 1
4) NM × NM MM n42 2p2q2(ψ2 + 2ψ1 + 1)/T ψ2/(ψ2 + 2ψ1 + 1)
NM n41 2ψ1/(ψ2 + 2ψ1 + 1)
NN n40 1/(ψ2 + 2ψ1 + 1)
5) NM × NN NM n51 2pq3(ψ1 + 1)/T ψ1/(ψ1 + 1)
NN n50 1/(ψ1 + 1)
6) NN × NN NN n60 q41/T 1
T = ψ2p2 + ψ12pq + q2BMC Proceedings 2007, 1(Suppl 1):S28 http://www.biomedcentral.com/1753-6561/1/S1/S28
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, and
 for (x0,  x1,
x2) = (0, x, 1) and N = R+S. Under the null hypothesis, ZCC
asymptotically follows the standard normal distribution.
Combined test of ZTDT and ZCC
Because the cases used in ZTDT and ZCC overlap, results
from the two tests are correlated, and this correlation, ρ,
must be considered when obtaining a combined test. By
noting that both tests are functions of a multinomial ran-
dom variable n with dimension 10 for the 10 nij categories
from Table 1, the correlation between ZTDT and ZCC can be
obtained given a specific genetic model (Appendix). The
probability of each category can be consistently estimated
by the observed counts and ρ can be consistently esti-
mated by the sample correlation between ZTDT and ZCC.
We propose the weighted average,
, as a test statistic in a
joint analysis. We consider a uniform weight, that is, w1 =
w2 = 1 [8,9] for simplicity. Other choices of weight, such
as a weight proportional to the number of informative
cases used in each test, can also be considered.
Two-stage method in large scale association studies
To test K markers in a two-stage analysis, we consider four
strategies that use either ZTDT or ZCC in the first stage based
on the intended design, and in each situation, the other
test or the joint test is applied in the second stage. As in
Skol et al. [6], we obtain thresholds C1 and C2 (or Cjoint)
for two stages in each strategy by controlling the genome-
wide significance level at α. C1 can be obtained as C1 = Φ-
1(1 - π1/2), where π1 is the proportion of markers selected
in the first stage. On the other hand, Cjoint and C2 need to
be calculated iteratively so that they satisfy
or
when the joint analysis is used or when the other test is
used. Here, Z1i and Z2i denote the tests used in the first and
the second stage for the ith SNP (Z2i is replaced by Zjointi
when the joint analysis is used in the second stage). We
need the subscript i because the correlations between two
tests for different SNPs are generally not the same. Under
HWE, however, we can show this correlation is a constant
(Appendix), and these equations can then be simplified to
P(|Z1| > C1, |Zjoint| > Cjoint) = α/K and P(|Z1| > C1, |Z2| >
C2, Z1Z2 > 0) = α/K.
Data
The Genetic Analysis Workshop 15 provided simulated
rheumatoid arthritis data that contain 1500 families with
affected sib pairs and their parents, and 2000 unrelated
controls on 9187 SNPs distributed throughout the
genome. We used the first simulated data set and we ran-
domly selected one from the affected sib pairs for data
analysis. The minor allele frequencies of all 9187 SNPs
were greater than 1%.
Results
To apply the two-stage analysis, we first obtained the
threshold for each strategy using π1 = 0.1 (C1 = 1.6449)
and Eq. (1) and (2). Therefore, we control the genome-
wide false-positive rate at 0.05, and we define a "signifi-
cant" SNP as one with test statistic greater than the thresh-
old in both stages. As expected, a slightly larger threshold
for the second stage is required for the joint analysis to
control the same genome-wide false-positive rate (C2 =
4.5121 vs. Cjoint = 4.5470) [6]. Table 2 summarizes results
based on an additive genetic model. The chromosome,
SNP name, and distance from the nearest major gene are
listed in the first three columns of the table, and if the SNP
was selected by the specified method (last three columns),
the p-value from the second stage is listed. We noticed that
even with a larger threshold required, the joint analysis in
the second stage found more significant SNPs near the
major genes. Also, we noticed that when the joint analysis
was used in the second stage, the same set of significant
SNPs was found regardless of the choice of the test statistic
in the first stage. However, different results were obtained
when either ZTDT or ZCC was used in the first stage fol-
lowed by the other test in the second stage. Specifically,
the joint analysis using either ZTDT or ZCC in the first stage
found 18 significant SNPs among which 9 and 14 were
located within 1 Mb (bold) and 5 Mb (italic) of the major
genes. When ZTDT in the first stage was followed by ZCC in
the second stage, we found 17 significant SNPs, and 8 of
these were located within 1 Mb of the causal genes, and 13
were located within 5 Mb. These methods found SNPs
near the major genes on chromosome 6, 11, and 18. On
the other hand, when we used ZCC in the first stage fol-
lowed by ZTDT in the second stage, a total of 10 significant
SNPs were found: 7 of them were located within 1 Mb of
a major gene only on chromosome 6 and 11, and 10 were
located within 5 Mb. A SNP near the major gene on chro-
mosome 18 was not found by this method.
When we applied these three tests (ZCC, ZTDT, Zjoint) to a
single-stage analysis, these tests found the same set of
Ux x RNr x RNs ii i ii i () ( / ) ( / ) =− − == ∑∑ 1 0
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SNPs identified in a two-stage analysis with the corre-
sponding test at the second stage. That is, ZCC, ZTDT, Zjointi
in a single-stage found 17, 10, and 18 SNPs in columns 4,
5, and 6 of Table 2. This implies that a two-stage analysis
can maintain power with a substantially reduced genotyp-
ing cost while controlling the same genome-wide false-
positive rate [6].
Discussion
In this paper, we presented a new method for testing asso-
ciation when both case-parents trios and unrelated con-
trols are available. Because parents are selected for having
an affected child, we consider the characteristics of non-
affected parents to be different from those of unrelated
controls in case-control studies. Thus, the genotype infor-
mation of parents was used only for ZTDT and not for ZCC.
By adjusting for the correlation between the two test sta-
tistics (ZTDT and ZCC), we proposed a combined test statis-
tic for analyzing such data.
For data with a large number of markers in a two-stage
analysis, we considered several analytical approaches fol-
lowing the method by Skol et al. [6]. Even with a slightly
larger threshold required, more SNPs near the major
genes were found using the joint analysis in the second
stage. Also, we noticed the choice of test for the first stage
was important when two separate tests were used in the
two stages, but when the joint analysis was used, the
impact of which test was used first seemed to be less
important. The added benefit of the joint analysis was
rather minor compared to what was studied by Skol et al.
[6] because the two tests for the first and the second stages
were highly correlated even without using the joint analy-
sis. Nevertheless, the joint analysis found slightly more
significant SNPs and is robust against the choice of the
first stage test. These properties suggest that the joint anal-
ysis would be desirable.
Our method can be generalized to data with missing gen-
otypes by either imputing the missing genotypes based on
partially available data [5,10], or by omitting cases with-
out complete parental information from ZTDT. In this sit-
uation, the correlation between ZTDT  and  ZCC  will
decrease, and therefore, the advantage of the joint analysis
could be accentuated. Complete justification, however,
requires further study.
Conclusion
We presented a new method for testing association when
data from both case-parents trios and unrelated controls
are available. By deriving the correlation of test statistics
for these two designs, we proposed a combined test as a
joint analysis. In a two-stage analysis for testing a large
number of markers, we found that the joint analysis
detects more SNPs near the major genes than other meth-
ods that do not use the combined test in the second stage.
This approach is also robust against the choice of the first
stage test.
Table 2: Two-stage analysis: selected SNPs and their corresponding p-values in the second stage
Chromosome SNP Distance (Mb) ZTDT then ZCC ZCC then ZTDT ZTDT or ZCC then Zjoint
6 SNP6_128 7.13 1.02 × 10-8 1.61 × 10-7
SNP6_129 7.10 4.01 × 10-13 1.45 × 10-8
SNP6_130 7.10 1.48 × 10-13 1.28 × 10-9
SNP6_134 6.41 5.76 × 10-10 1.33 × 10-6
SNP6_138b 3.73 2.89 × 10-15 2.85 × 10-7 1.07 × 10-13
SNP6_139 3.72 2.44 × 10-15 3.75 × 10-7 1.22 × 10-13
SNP6_145 2.92 1.03 × 10-9 5.20 × 10-6 1.24 × 10-9
SNP6_147 2.22 1.37 × 10-8 3.05 × 10-7
SNP6_150 1.39 5.99 × 10-7 6.25 × 10-7
SNP6_152c 0.04 2.38 × 10-221 1.55 × 10-94 4.31 × 10-193
SNP6_153 0.01 0*a 7.33 × 10-206 0*a
SNP6_154 0.04 0* 1.23 × 10-182 0*
SNP6_155 0.29 4.49 × 10-87 1.91 × 10-49 7.36 × 10-86
SNP6_160 0.65 8.62 × 19-10 8.20 × 10-9 1.16 × 10-11
SNP6_162 0.13 9.15 × 10-24 1.78 × 10-15 9.36 × 10-26
11 SNP11_387 0.19 3.00 × 10-6
SNP11_389 0.03 2.78 × 10-28 3.33 × 10-15 2.41 × 10-27
18 SNP18_269 0.02 2.25 × 10-8 1.56 × 10-8
a0*, p-value < 10-300. Test statistics are based on an additive genetic model.
bItalic, SNPs within 5 Mb of the major genes.
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Appendix
When the conditional likelihood is used for ZTDT, n1 = n12,
n2 = (n21, n22), n3 = n31, n4 = (n40, n41, n42), n5 = (n50, n51),
and  n6 =  n60 are independent random variables condi-
tional on parental mating types (m) where n2 and n5 fol-
low a binomial distribution and n4 follows a trinomial
distribution with probabilities given in column 5 of Table
1[2]. The score test for H0:  ψ  = 1 is then written as
, where UT(n) = n22+n42,
n22+n42+0.5(n21+n41+n51) and n42+n41+n51 for the reces-
sive, additive, and dominant models. By applying the var-
iance decomposition formula, we obtain the correlation
between ZTDT and ZCC as .
An additional distributional assumption needs to be
made for parental genotypes. We considered six parental
mating types as a six dimensional multinomial distribu-
tion, and the corresponding probabilities were consist-
ently estimated by the observed counts.
Under HWE, we can show that the correlation for three
models can be simplified to   when all cases
have parental genotypes available. When only a propor-
tion of cases overlaps between case-parents and case-con-
trol designs, we can introduce an additional parameter η
< 1 such that  , and the correlation between
ZTDT and ZCC is reduced to  .
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